ID   HSC-M1
AC   CVCL_H630
DR   Wikidata; Q54896416
RX   PubMed=11426532;
RX   PubMed=15356658;
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=11426532).
CC   Miscellaneous: Cell line has been lost (PubMed=15356658).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
RX   PubMed=11426532; DOI=10.3109/10428190109097658;
RA   Al-Hashmi I., Decoteau J., Gruss H.-J., Zielenska M., Thorner P.S.,
RA   Poon A.O., Reis M.D., Freedman M.H., Lorenzana A.N.;
RT   "Establishment of a cytokine-producing anaplastic large-cell lymphoma
RT   cell line containing the t(2;5) translocation: potential role of
RT   cytokines in clinical manifestations.";
RL   Leuk. Lymphoma 40:599-611(2001).
//
RX   PubMed=15356658; DOI=10.1038/sj.leu.2403465;
RA   Drexler H.G., MacLeod R.A.F.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   anaplastic large-cell lymphoma.";
RL   Leukemia 18:1569-1571(2004).
//